Renalytix reported revenue of $0.52M and net income of -$4.73M for the quarter ended Sep 2024, up 13.7% year over year. This income statement covers 19 quarters of results from Jun 2018 through Sep 2024, standardized by Business Quant from the company’s SEC filings.
| Income StatementIncome Statement | Jun2018 | Jun2019 | Jun2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | |||||||||||||||||||
| Revenue | 0.40M | 0.62M | 0.47M | 0.48M | 0.85M | 0.81M | 0.83M | 0.97M | 1.19M | 0.72M | 0.52M | 0.46M | 0.71M | 0.54M | 0.59M | 0.52M | |||
| Cost of RevenueCost of Rev | 0.26M | 0.17M | 0.43M | 0.23M | 0.49M | 0.69M | 0.69M | 0.70M | 0.71M | 0.60M | 0.67M | 0.50M | 0.48M | 0.60M | 0.55M | 0.42M | |||
| Gross Profit | 0.14M | 0.45M | 0.04M | 0.26M | 0.35M | 0.13M | 0.14M | 0.27M | 0.48M | 0.12M | -0.16M | -0.04M | 0.23M | -0.07M | 0.04M | 0.10M | |||
| Operating items | |||||||||||||||||||
| Research & DevelopmentR&D | 2.46M | 3.10M | 2.73M | 4.00M | 4.13M | 3.89M | 2.63M | 3.76M | 3.33M | 3.94M | 3.27M | 2.79M | 3.23M | 2.22M | 1.06M | 0.92M | |||
| Selling, General & AdministrativeSG&A | 6.60M | 5.55M | 7.22M | 8.13M | 10.07M | 10.81M | 10.51M | 8.25M | 6.81M | 7.10M | 6.51M | 6.06M | 5.34M | 3.85M | 4.50M | 3.27M | |||
| Other Operating ExpensesOther Opex | -0.30M | -0.13M | -0.08M | -0.06M | -0.07M | -0.03M | 0.05M | -0.01M | -0.01M | 0.31M | 0.42M | ||||||||
| Operating ExpensesOpex | 8.76M | 8.52M | 9.87M | 12.07M | 14.14M | 14.66M | 13.19M | 12.00M | 10.13M | 11.04M | 9.78M | 8.85M | 8.87M | 6.49M | 5.56M | 4.19M | |||
| Operating IncomeOp. Inc | -8.61M | -8.07M | -9.83M | -11.81M | -13.78M | -14.54M | -13.05M | -11.72M | -9.65M | -10.92M | -9.93M | -8.89M | -8.64M | -6.55M | -5.53M | -4.09M | |||
| Non-operating items | |||||||||||||||||||
| Other Non Operating IncomeOther Non Op Inc. | -5.43M | -1.03M | 0.76M | 2.32M | -0.16M | 2.44M | 5.23M | 1.84M | -0.01M | -0.15M | 0.26M | 0.39M | 0.07M | -0.03M | -0.02M | 0.03M | |||
| Net income details | |||||||||||||||||||
| EBIT | -8.61M | -8.07M | -9.83M | -11.81M | -13.78M | -14.54M | -13.05M | -11.72M | -9.65M | -10.92M | -9.93M | -8.89M | -8.64M | -6.55M | -5.53M | -4.09M | |||
| EBT | -8.61M | -8.07M | -9.83M | -10.11M | -15.32M | -14.70M | -5.13M | -11.95M | -10.44M | -12.11M | -11.10M | -10.15M | -8.48M | -7.74M | -7.07M | -4.73M | |||
| Tax ProvisionsTaxes | 0.03M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | |||||||||||||
| Income After Tax | -8.61M | -8.07M | -9.83M | -10.11M | -15.32M | -14.70M | -5.15M | -11.96M | -10.44M | -12.11M | -11.10M | -10.15M | -8.49M | -7.74M | -7.07M | -4.73M | |||
| Equity Income | -0.11M | -0.01M | -1.88M | 0.04M | -0.03M | 0.00M | -0.01M | ||||||||||||
| Income from Continuing OperationsIncome (Continuing) | -8.61M | -8.07M | -9.83M | -10.11M | -15.32M | -14.70M | -5.15M | -11.96M | -10.44M | -12.11M | -11.10M | -10.15M | -8.49M | -7.74M | -7.07M | -4.73M | |||
| Consolidated Net IncomeConsol Net Inc. | -8.61M | -8.07M | -9.83M | -10.11M | -15.32M | -14.70M | -5.15M | -11.96M | -10.44M | -12.11M | -11.10M | -10.15M | -8.49M | -7.74M | -7.07M | -4.73M | |||
| Net Income Attributable to Noncontrolling InterestsNCI Net Income | -0.22M | 1.22M | |||||||||||||||||
| Income towards Parent CompanyParent Net Inc | -9.13M | -8.78M | -9.82M | -10.11M | -15.32M | -14.70M | -5.15M | -11.95M | -10.44M | -12.11M | -11.10M | -10.15M | -8.49M | -7.74M | -7.07M | -4.73M | |||
| Net Income towards Common StockholdersNet Income | -8.91M | -8.78M | -9.82M | -10.11M | -15.32M | -14.70M | -5.15M | -11.95M | -10.44M | -12.11M | -11.10M | -10.15M | -8.49M | -7.74M | -7.07M | -4.73M | |||
| Additional items | |||||||||||||||||||
| EPS (Basic) | -0.30 | -0.30 | -0.27 | -0.28 | -0.43 | -0.41 | -0.14 | -0.32 | -0.28 | -0.28 | -0.27 | -0.21 | -0.17 | -0.16 | -0.13 | -0.09 | |||
| EPS (Diluted) | -0.30 | -0.30 | -0.27 | -0.28 | -0.43 | -0.41 | -0.14 | -0.32 | -0.28 | -0.28 | -0.27 | -0.21 | -0.17 | -0.16 | -0.13 | -0.09 | |||
| Shares Outstanding | 10.00M | 21.28M | 29.54M | 29.54M | 29.54M | 35.74M | 35.74M | 35.74M | 35.74M | 36.43M | 37.40M | 37.45M | 42.78M | 41.11M | 47.38M | 48.63M | 48.83M | 54.09M | 52.85M |
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 29.54M | 29.54M | 29.54M | 35.74M | 35.74M | 35.74M | 35.74M | 36.92M | 37.40M | 37.45M | 42.78M | 41.11M | 47.38M | 48.63M | 48.83M | 54.09M | 52.85M | ||
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 10.00M | 21.28M | 29.71M | 36.10M | 37.38M | 37.45M | 37.45M | 46.89M | 47.51M | 48.72M | 49.97M | 48.83M | 54.09M | 52.85M | |||||
| EBITDA | -8.56M | -7.99M | -9.73M | -11.70M | -13.68M | -14.41M | -12.92M | -11.59M | -9.52M | -10.79M | -9.81M | -8.76M | -8.53M | -6.48M | -5.47M | -4.03M |
Pull Renalytix's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=RNLXY&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "RNLXY", "statement": "IS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=RNLXY&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();